Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Treatment for glaucoma: adherence by the elderly.

Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J.

Am J Public Health. 1993 May;83(5):711-6.

PMID:
8484454
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A comprehensive perspective on patient adherence to topical glaucoma therapy.

Tsai JC.

Ophthalmology. 2009 Nov;116(11 Suppl):S30-6. doi: 10.1016/j.ophtha.2009.06.024. Review.

PMID:
19837258
[PubMed - indexed for MEDLINE]
3.

Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population.

Bhosle MJ, Reardon G, Camacho FT, Anderson RT, Balkrishnan R.

Am J Geriatr Pharmacother. 2007 Jun;5(2):100-11.

PMID:
17719512
[PubMed - indexed for MEDLINE]
4.

Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?

Robin AL, Covert D.

Ophthalmology. 2005 May;112(5):863-8.

PMID:
15878067
[PubMed - indexed for MEDLINE]
5.

Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.

Rees G, Leong O, Crowston JG, Lamoureux EL.

Ophthalmology. 2010 May;117(5):903-8. doi: 10.1016/j.ophtha.2009.10.038. Epub 2010 Feb 13.

PMID:
20153902
[PubMed - indexed for MEDLINE]
6.

Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.

Hertz RP, Unger AN, Lustik MB.

Clin Ther. 2005 Jul;27(7):1064-73.

PMID:
16154485
[PubMed - indexed for MEDLINE]
7.

Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data.

Dasgupta S, Oates V, Bookhart BK, Vaziri B, Schwartz GF, Mozaffari E.

Am J Manag Care. 2002 Aug;8(10 Suppl):S255-61.

PMID:
12188168
[PubMed - indexed for MEDLINE]
Free Article
8.

Discontinuation rates of topical glaucoma medications in a managed care population.

Shaya FT, Mullins CD, Wong W, Cho J.

Am J Manag Care. 2002 Aug;8(10 Suppl):S271-7.

PMID:
12188170
[PubMed - indexed for MEDLINE]
Free Article
9.

Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.

Nichol MB, Knight TK, Wu J, Barron R, Penson DF.

J Urol. 2009 May;181(5):2214-21; discussion 2221-2. doi: 10.1016/j.juro.2009.01.033. Epub 2009 Mar 17.

PMID:
19296986
[PubMed - indexed for MEDLINE]
10.

Patient-centered communication to assess and enhance patient adherence to glaucoma medication.

Hahn SR.

Ophthalmology. 2009 Nov;116(11 Suppl):S37-42. doi: 10.1016/j.ophtha.2009.06.023. Review.

PMID:
19837259
[PubMed - indexed for MEDLINE]
11.

Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.

Reardon G, Schwartz GF, Mozaffari E.

Clin Ther. 2003 Apr;25(4):1172-85.

PMID:
12809964
[PubMed - indexed for MEDLINE]
12.

Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).

Vandenbroeck S, De Geest S, Dobbels F, Fieuws S, Stalmans I, Zeyen T.

J Glaucoma. 2011 Sep;20(7):414-21. doi: 10.1097/IJG.0b013e3181f7b10e.

PMID:
21048510
[PubMed - indexed for MEDLINE]
13.

Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization.

Balkrishnan R, Bond JB, Byerly WG, Camacho FT, Anderson RT.

Am J Geriatr Pharmacother. 2003 Dec;1(2):75-81.

PMID:
15555469
[PubMed - indexed for MEDLINE]
14.

Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada.

Evans CD, Eurich DT, Lamb DA, Taylor JG, Jorgenson DJ, Semchuk WM, Mansell KD, Blackburn DF.

J Manag Care Pharm. 2009 Jul-Aug;15(6):476-84.

PMID:
19610680
[PubMed - indexed for MEDLINE]
Free Article
15.

Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.

Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain RL, Swindle RW.

J Manag Care Pharm. 2006 Jan-Feb;12(1):43-54.

PMID:
16420107
[PubMed - indexed for MEDLINE]
Free Article
16.

A clinician's guide to the assessment and management of nonadherence in glaucoma.

Budenz DL.

Ophthalmology. 2009 Nov;116(11 Suppl):S43-7. doi: 10.1016/j.ophtha.2009.06.022. Review.

PMID:
19837260
[PubMed - indexed for MEDLINE]
17.

Hypertension treatment in a medicare population: adherence and systolic blood pressure control.

Fung V, Huang J, Brand R, Newhouse JP, Hsu J.

Clin Ther. 2007 May;29(5):972-84.

PMID:
17697916
[PubMed - indexed for MEDLINE]
18.

Multicenter study of compliance and drop administration in glaucoma.

Kholdebarin R, Campbell RJ, Jin YP, Buys YM.

Can J Ophthalmol. 2008 Aug;43(4):454-61. doi: 10.1139/i08-076.

PMID:
18711461
[PubMed - indexed for MEDLINE]
19.

Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study.

Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SS.

Drugs Aging. 2008;25(10):885-92.

PMID:
18808213
[PubMed - indexed for MEDLINE]
20.

Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma.

Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J.

Med Care. 1998 Mar;36(3):357-69.

PMID:
9520960
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk